EUCTR2016-002083-13-GB进行中（未招募）1 期
An observational follow up study of a randomised parallel group phase IV study to evaluate the duration of the immune response to vaccine and non-vaccine HPV types in UK adolescent females who received either Cervarix or Gardasil Human Papillomavirus (HPV) vaccines. - HPV vaccinee follow up from previous studyEUDRACT study 2008-006773-32
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. Participant is willing and able to give written informed consent for participation.
- •2. Participation in the original study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 50
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 148
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Known bleeding diathesis (or any condition that may be associated with a prolonged bleeding time).
- •Any other significant condition or circumstance which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study.
研究者
相似试验
尚未招募
不适用
Mercurius 5 years follow-up studyHealthy infantsNL-OMON28614utricia Research230
尚未招募
Unknown
This study is intended to find out whether short axis or long axis of ultrasound is better for internal jugular vein cannulation in terms of time requiredCTRI/2024/01/061180Department of Anesthesiology, S.M.S And Attached Groups of Hospitals
招募中
不适用
An Ayurvedic Management of Sensory Neural Hearing LossCTRI/2019/09/021280DR RAMYA
招募中
不适用
A prospective longitudinal observational study of health status in patients with lung cancer (TOSEI-LC)ung cancerJPRN-UMIN000030481Department of Respiratory Medicine and Allergy, Tosei General Hospital90
进行中（未招募）
不适用
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis - RESTORE™ SIntravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)MedDRA version: 9.0Level: LLTClassification code 10045365EUCTR2005-004105-28-GRPDL BioPharma, Inc.300